Proteoglycan expression correlates with the phenotype of malignant and non-malignant EBV-positive B-cell lines

Por Tsidulko, Alexandra Y., Matskova, Liudmila, Astakhova, Lidiia A., Ernberg, Ingemar, Grigorieva, Elvira V.
Publicado no Oncotarget (2015)

Tissue-specificity of heparan sulfate biosynthetic machinery in cancer

Por Suhovskih, Anastasia V, Domanitskaya, Natalya V, Tsidulko, Alexandra Y, Prudnikova, Tatiana Y, Kashuba, Vladimir I, Grigorieva, Elvira V
Publicado no Cell Adh Migr (2015)

Transcriptional Activity of Heparan Sulfate Biosynthetic Machinery is Specifically Impaired in Benign Prostate Hyperplasia and Prostate Cancer

Por Suhovskih, Anastasia V., Tsidulko, Alexandra Y., Kutsenko, Olesya S., Kovner, Anna V., Aidagulova, Svetlana V., Ernberg, Ingemar, Grigorieva, Elvira V.
Publicado em 2014

Conventional Anti-glioblastoma Chemotherapy Affects Proteoglycan Composition of Brain Extracellular Matrix in Rat Experimental Model in vivo

Por Tsidulko, Alexandra Y., Bezier, Cynthia, de La Bourdonnaye, Gabin, Suhovskih, Anastasia V., Pankova, Tatiana M., Kazanskaya, Galina M., Aidagulova, Svetlana V., Grigorieva, Elvira V.
Publicado no Front Pharmacol (2018)

Heparan Sulfate Biosynthetic System Is Inhibited in Human Glioma Due to EXT1/2 and HS6ST1/2 Down-Regulation

Por Ushakov, Victor S., Tsidulko, Alexandra Y., de La Bourdonnaye, Gabin, Kazanskaya, Galina M., Volkov, Alexander M., Kiselev, Roman S., Kobozev, Vyacheslav V., Kostromskaya, Diana V., Gaytan, Alexey S., Krivoshapkin, Alexei L., Aidagulova, Svetlana V., Grigorieva, Elvira V.
Publicado no Int J Mol Sci (2017)